To test whether the TFCOs would also respond to TSHR-Abs, we incubated human TFCOs with sera from a Graves’ disease patient (GD serum) (TSHR-Ab titers >3.3 IU/L) at different dilutions for 10 d. The gene discussed is TSHR; the disease is Graves disease.